
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL_L | 456 | 97.6% | 1.37 | 1,178 | 92.2% |
| AL_R | 5 | 1.1% | 4.02 | 81 | 6.3% |
| CRE_R | 1 | 0.2% | 3.46 | 11 | 0.9% |
| EB | 4 | 0.9% | 1.00 | 8 | 0.6% |
| MB_ML_R | 1 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns lLN9,lLN17a | % In | CV |
|---|---|---|---|---|---|
| ORN_VA1v (L) | 31 | ACh | 33 | 16.4% | 0.6 |
| lLN9,lLN17a (L) | 2 | ACh | 17.5 | 8.7% | 0.2 |
| ORN_DA1 (L) | 19 | ACh | 17.5 | 8.7% | 0.6 |
| ALIN6 (R) | 1 | GABA | 11.5 | 5.7% | 0.0 |
| v2LN36 (L) | 1 | 5-HT | 7 | 3.5% | 0.0 |
| ORN_VA1v (na) | 5 | 5-HT | 7 | 3.5% | 0.7 |
| ORN_VA3 (L) | 7 | ACh | 5 | 2.5% | 0.3 |
| OA-VUMa5 (M) | 2 | OA | 4.5 | 2.2% | 0.6 |
| ORN_DC3 (L) | 5 | ACh | 4 | 2.0% | 0.5 |
| ORN_VA1v (R) | 8 | 5-HT | 4 | 2.0% | 0.0 |
| lLN2P_a (L) | 5 | Unk | 3.5 | 1.7% | 0.3 |
| ORN_VA1d (L) | 7 | Unk | 3.5 | 1.7% | 0.0 |
| ALIN3 (L) | 1 | ACh | 2.5 | 1.2% | 0.0 |
| lLN2X10 (L) | 2 | ACh | 2.5 | 1.2% | 0.2 |
| ORN_VM5d (L) | 4 | ACh | 2.5 | 1.2% | 0.3 |
| lLN2X12 (L) | 3 | Unk | 2.5 | 1.2% | 0.3 |
| lLN2T_c (L) | 2 | 5-HT | 2.5 | 1.2% | 0.2 |
| v2LN3A1_b (L) | 3 | Unk | 2.5 | 1.2% | 0.3 |
| lLN2F_b (L) | 2 | GABA | 2 | 1.0% | 0.5 |
| VM5v_adPN (L) | 3 | ACh | 2 | 1.0% | 0.4 |
| ORN_D (L) | 4 | ACh | 2 | 1.0% | 0.0 |
| ORN_DA1 (R) | 4 | ACh | 2 | 1.0% | 0.0 |
| lLN1_bc (L) | 3 | Unk | 2 | 1.0% | 0.4 |
| v2LN30 (L) | 1 | Unk | 1.5 | 0.7% | 0.0 |
| ORN_DL2v (R) | 1 | ACh | 1.5 | 0.7% | 0.0 |
| ORN_VM5v (L) | 2 | ACh | 1.5 | 0.7% | 0.3 |
| DA1_lPN (L) | 2 | ACh | 1.5 | 0.7% | 0.3 |
| ORN_VA6 (L) | 2 | ACh | 1.5 | 0.7% | 0.3 |
| AL-MBDL1 (R) | 1 | Unk | 1.5 | 0.7% | 0.0 |
| ORN_DP1l (L) | 2 | ACh | 1.5 | 0.7% | 0.3 |
| AL-MBDL1 (L) | 1 | Unk | 1.5 | 0.7% | 0.0 |
| DC3_adPN (L) | 1 | ACh | 1.5 | 0.7% | 0.0 |
| lLN2X09 (L) | 1 | ACh | 1.5 | 0.7% | 0.0 |
| CB1676 (L) | 1 | Unk | 1.5 | 0.7% | 0.0 |
| ORN_VA1d (R) | 3 | Unk | 1.5 | 0.7% | 0.0 |
| M_lvPNm41 (L) | 2 | ACh | 1.5 | 0.7% | 0.3 |
| VC3_adPN (L) | 3 | ACh | 1.5 | 0.7% | 0.0 |
| lLN9,lLN17a (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| lLN2T_d (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| DNp32 (L) | 1 | DA | 1 | 0.5% | 0.0 |
| VA7l_adPN (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| ORN_DA4l (L) | 1 | 5-HT | 1 | 0.5% | 0.0 |
| lLN2T_b (L) | 1 | Unk | 1 | 0.5% | 0.0 |
| lLN1_a (L) | 2 | 5-HT | 1 | 0.5% | 0.0 |
| DM5_lPN (L) | 2 | ACh | 1 | 0.5% | 0.0 |
| LN60b (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| CB2908 (L) | 2 | GABA | 1 | 0.5% | 0.0 |
| M_lPNm11D (L) | 2 | ACh | 1 | 0.5% | 0.0 |
| M_lvPNm42 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| vLN24 (L) | 1 | Unk | 1 | 0.5% | 0.0 |
| ALIN7 (R) | 1 | GABA | 1 | 0.5% | 0.0 |
| lLN2X05 (L) | 1 | 5-HT | 1 | 0.5% | 0.0 |
| ORN_D (R) | 2 | ACh | 1 | 0.5% | 0.0 |
| ORN_DM3 (L) | 2 | 5-HT | 1 | 0.5% | 0.0 |
| CB1141,CB1285 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| VA1d_adPN (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN2F_a (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.5 | 0.2% | 0.0 |
| CB1676 (R) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| AL-AST1 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB3326 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| M_spPN4t9 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN2X04 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| M_lvPNm40 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| VM5d_adPN (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB1266 (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| il3LN6 (R) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| CB3679 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| ORN_DL2v (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| ALON3 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| CB1473 (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| LN60a (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| CB0683 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| ORN_DA2 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN10 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| v2LN37 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| ALIN3 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB1132 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| ORN_VA3 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB2504 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| MZ_lv2PN (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| LN60b (R) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| CB1546 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| lLN2P_b (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| CB3007 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| vLN26 (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| DL2v_adPN (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| ORN_VA3 (na) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| ORN_DA4l (na) | 1 | 5-HT | 0.5 | 0.2% | 0.0 |
| v2LNX01 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| CB1824 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| DNc01 (R) | 1 | DA | 0.5 | 0.2% | 0.0 |
| M_lvPNm31 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| DA4l_adPN (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| downstream partner | # | NT | conns lLN9,lLN17a | % Out | CV |
|---|---|---|---|---|---|
| VA1v_adPN (L) | 4 | ACh | 59 | 17.9% | 0.2 |
| ORN_VA1v (L) | 29 | ACh | 56 | 16.9% | 0.6 |
| VA1d_adPN (L) | 2 | ACh | 31.5 | 9.5% | 0.3 |
| ORN_VA1d (L) | 23 | ACh | 20.5 | 6.2% | 0.5 |
| lLN9,lLN17a (L) | 2 | ACh | 17.5 | 5.3% | 0.2 |
| ORN_VA1v (R) | 22 | ACh | 17 | 5.1% | 0.5 |
| lLN2P_a (L) | 7 | Unk | 13.5 | 4.1% | 0.4 |
| ORN_VA1d (R) | 19 | ACh | 12.5 | 3.8% | 0.5 |
| D_adPN (L) | 3 | ACh | 10.5 | 3.2% | 0.1 |
| lLN2P_b (L) | 6 | GABA | 8.5 | 2.6% | 0.4 |
| VA1v_vPN (L) | 2 | GABA | 8 | 2.4% | 0.0 |
| ORN_VA1v (na) | 4 | 5-HT | 7 | 2.1% | 0.2 |
| lLN1_bc (L) | 9 | Unk | 5.5 | 1.7% | 0.3 |
| DA1_lPN (L) | 5 | ACh | 5 | 1.5% | 0.4 |
| VM5d_adPN (L) | 3 | ACh | 4 | 1.2% | 0.2 |
| v2LN36 (L) | 1 | 5-HT | 3.5 | 1.1% | 0.0 |
| DC3_adPN (L) | 3 | ACh | 3.5 | 1.1% | 0.4 |
| VA3_adPN (L) | 2 | ACh | 3 | 0.9% | 0.0 |
| ALON3 (L) | 2 | GABA | 2 | 0.6% | 0.5 |
| v2LN30 (L) | 1 | Unk | 2 | 0.6% | 0.0 |
| M_vPNml79 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| CB2571 (L) | 2 | ACh | 2 | 0.6% | 0.5 |
| ORN_DA4l (L) | 2 | Unk | 2 | 0.6% | 0.0 |
| ORN_D (L) | 3 | ACh | 2 | 0.6% | 0.4 |
| lLN2P_b (R) | 1 | Unk | 1.5 | 0.5% | 0.0 |
| ORN_DL5 (R) | 1 | Unk | 1.5 | 0.5% | 0.0 |
| VP1d+VP4_l2PN1 (R) | 1 | ACh | 1.5 | 0.5% | 0.0 |
| lLN8 (L) | 1 | GABA | 1.5 | 0.5% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 1.5 | 0.5% | 0.0 |
| M_vPNml79 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| DA1_lPN (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1673 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| v2LN37 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| lLN2X10 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| ORN_D (R) | 2 | ACh | 1 | 0.3% | 0.0 |
| ORN_VA1d (na) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB3007 (L) | 2 | GABA | 1 | 0.3% | 0.0 |
| ORN_DA1 (L) | 2 | ACh | 1 | 0.3% | 0.0 |
| M_vPNml65 (L) | 2 | GABA | 1 | 0.3% | 0.0 |
| lLN2X03 (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.5 | 0.2% | 0.0 |
| lLN2T_e (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| lLN2X12 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| ORN_DC2 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB3575 (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| M_spPN4t9 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.5 | 0.2% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| VA1d_adPN (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB1132 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| v2LN36 (R) | 1 | 5-HT | 0.5 | 0.2% | 0.0 |
| CB1686 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| LN60a (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| VA2_adPN (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| CB2527 (L) | 1 | Glu | 0.5 | 0.2% | 0.0 |
| VP1d+VP4_l2PN2 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN2X02 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| M_ilPNm90,M_ilPN8t91 (R) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN9 (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| DC2_adPN (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| M_l2PNm16 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| lLN9,lLN17a (R) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| M_lvPNm41 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| M_vPNml84 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| CB1824 (L) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| ORN_DC3 (L) | 1 | ACh | 0.5 | 0.2% | 0.0 |
| v2LN34E (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |
| lLN2T_b (L) | 1 | Unk | 0.5 | 0.2% | 0.0 |